Cargando...
Chimeric Antigen Receptor T-Cell Therapy: A Beacon of Hope in the Fight Against Cancer
Despite significant advancements, relapses, and persistent malignancies are still a major challenge faced by the oncologists. Immunotherapy has shown remarkable potential in induction of sustained remission in refractory malignancies. Chimeric antigen receptor T-cell (CAR-T) therapy is a newer treat...
Gardado en:
| Publicado en: | Cureus |
|---|---|
| Main Authors: | , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
Cureus
2018
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6314790/ https://ncbi.nlm.nih.gov/pubmed/30613448 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7759/cureus.3486 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|